Pharmaceutical salts and polymorphs of N- (5-CHLORO-2-PYRIDINYL) -2- [ [4- [ (DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO] - 5-METH OXY-BENZAMIDE, a factor XA inhibitor

Details for Australian Patent Application No. 2006311544 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Langlands, Graeme; Kanter, James P.; Grant, Craig

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006311544

PCT Pub. Number WO2007/056517

Priority 60/735,224 08.11.05 US

Filing date 7 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 8 March 2012

International Classifications

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056517 Priority application(s): WO2007/056517

15 May 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pharmaceutical salts and polymorphs of N- (5-CHLORO-2-PYRINDYL) -2- [ [4- [ (DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO] -5-METH OXY-BENZAMIDE, a factor XA inhibitor

8 March 2012 Application Accepted

  Published as AU-B-2006311544

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311545-Solid oxid fuel cell device comprising an elongated substrate with a hot and a cold portion

2006311538-Metal-binding therapeutic peptides